SAN DIEGO, May 13, 2020 /PRNewswire/ -- Evofem
Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage
biopharmaceutical company, today announced that it will participate
in the upcoming 2020 RBC Capital Markets Global Healthcare
Conference.
Evofem Executive Team members will participate in a virtual
fireside chat on Tuesday, May 19,
2020 from 4:15 pm –
4:40 pm EDT. A
simultaneous live audio webcast will also be available.
The archived webcast of the fireside chat will be available
following the presentation via the Evofem Biosciences website at
www.evofem.com, under the Investors section.
About Evofem Biosciences, Inc.
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a clinical-stage
biopharmaceutical company committed to developing and
commercializing innovative products to address unmet needs in
women's sexual and reproductive health. Evofem Biosciences aims to
advance the lives of women by developing innovative solutions, such
as woman-controlled contraception and potential protection from
certain sexually transmitted infections (STIs). The Company's lead
product candidate, Phexxi™, is currently being reviewed by the U.S.
Food and Drug Administration for prevention of pregnancy. The
investigational candidate EVO100 is being evaluated for prevention
of urogenital transmission of both Chlamydia
trachomatis infection (chlamydia) and Neisseria
gonorrhoeae infection (gonorrhea) in women. For more
information regarding Evofem, please visit www.evofem.com.
Phexxi™ and Multipurpose Vaginal pH Regulator (MVP-R™) are
trademarks of Evofem Biosciences, Inc.
Investor Contact
Amy
Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
M: (917) 673-5775
Media Contact
Cara
Miller
Evofem Biosciences, Inc.
cmiller@evofem.com
O: (858) 550-1900 x272
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-participate-in-virtual-fireside-chat-at-rbc-capital-markets-global-healthcare-conference-301058187.html
SOURCE Evofem Biosciences, Inc.